Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 23,150 KRW
Change Today -350.00 / -1.49%
Volume 40.1K
003220 On Other Exchanges
Korea SE
As of 2:28 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

Year over year, Daewon Pharmaceutical Co. Ltd. has been able to grow revenues from 158.9B KRW to 182.0B KRW. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 47.27% to 45.64%. This was a driver that led to a bottom line growth from 12.3B KRW to 15.7B KRW.
View Income Statement In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
Other Revenues0.0------
TOTAL REVENUES138,874.7138,168.5158,878.9181,984.5
Cost of Goods Sold62,757.566,792.175,100.083,054.6
GROSS PROFIT76,117.271,376.483,778.898,929.9
Selling General & Admin Expenses, Total52,762.951,130.360,470.468,962.8
R&D Expenses5,680.74,785.55,753.910,038.0
Depreciation & Amortization, Total737.2931.2975.8981.5
Other Operating Expenses3,554.81,059.21,034.31,147.2
OTHER OPERATING EXPENSES, TOTAL62,735.657,906.368,234.581,129.4
OPERATING INCOME13,381.613,470.115,544.317,800.5
Interest Expense-285.6-226.5-126.1-100.5
Interest and Investment Income356.0694.7751.7741.4
NET INTEREST EXPENSE70.4468.2625.6641.0
Currency Exchange Gains (Loss)62.6-109.2155.0134.2
Other Non-Operating Income (Expenses)-205.6221.6278.82,708.5
EBT, EXCLUDING UNUSUAL ITEMS13,309.014,050.816,603.821,284.2
Gain (Loss) on Sale of Investments-64.9-737.7-63.5235.9
Gain (Loss) on Sale of Assets-115.1-10.6-172.024.9
Other Unusual Items, Total-600.0-747.3-766.1-420.7
EBT, INCLUDING UNUSUAL ITEMS12,529.112,555.215,602.221,124.3
Income Tax Expense3,272.22,789.13,368.95,527.0
Minority Interest in Earnings179.4-151.487.7131.2
Earnings from Continuing Operations9,256.99,766.212,233.315,597.4
NET INCOME9,436.49,614.812,320.915,728.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS9,436.49,614.812,320.915,728.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS9,436.49,614.812,320.915,728.5

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 23,150.00 KRW -350.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies

Industry Analysis


Industry Average

Valuation 003220 Industry Range
Price/Earnings 18.4x
Price/Sales 1.9x
Price/Book 2.7x
Price/Cash Flow 18.6x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at